Neisseria meningitidis Serogroup B Outbreak in the United Kingdom Investigated Using Next-Generation Sequencing-Driven Whole Genome Analysis

In March 2026, the United Kingdom experienced an unusual outbreak of invasive meningococcal disease caused by Neisseria meningitidis serogroup B (MenB), centered on Canterbury and particularly affecting University of Kent students and other young people [1,2].Furthermore, MenB cases and clusters have also occurred in Dorset and Reading in April and May.N. meningitidis is a Gram-negative, encapsulated bacterium that can colonize the human nasopharynx without causing symptoms.In some individuals, however, it can invade the bloodstream or cross the blood-brain barrier, causing serious invasive meningococcal diseases including acute bacterial meningitis.The disease can progress rapidly and may be fatal, even in previously healthy individuals.Transmission of N. meningitidis occurs mainly through respiratory and oral secretions during close or prolonged contact, such as kissing, sharing saliva or drinks, household contact, and living in communal accommodation.Adolescents and young adults are therefore at increased risk of carrying and transmitting N. meningitidis, although invasive disease can occur at any age.N. meningitidis is subclassified into serogroups according to the antigenic properties of its polysaccharide capsule, an important virulence factor that helps the bacterium evade phagocytosis and the human immune system.There are 12 recognized serogroups, with the most invasive meningococcal diseases caused by serogroups A, B, C, W, X and Y. Serogrouping helps in epidemiological surveillance by identifying which serogroups are responsible for the meningococcal infections in a particular population or geographical area.It is also useful in outbreak investigation, as identification of the same serogroup in multiple patients can help establish a potentially common source or transmission pattern.Furthermore, serogroup information is of paramount importance for vaccine selection and prevention.Available meningococcal vaccines provide protection against specific serogroups, so knowledge of circulating serogroups helps health authorities select appropriate vaccination strategies.During outbreaks, serogroup identification can also guide decisions regarding vaccination of at-risk populations and close contacts.This meningococcal outbreak in the United Kingdom was first recognized in Kent in March 2026, when an unusual number of young people developed invasive meningococcal disease over a very short period [1,2].Most of those affected were students at the University of Kent in Canterbury and sixth-form students from local schools.The speed of the outbreak was particularly striking, in that 15 cases were reported within 48 h.This was very different from the usual pattern of meningococcal outbreaks.In England, roughly 300-400 cases of meningococcal disease occur in a typical year, while most clusters involve only 2-4 cases spread over a longer period.By the end of March, there were 21 laboratory confirmed cases linked to the Kent outbreak, including two deaths.The two fatalities involved a 21-year-old University of Kent student and a sixth-form student.Both cases deteriorated dramatically within hours and succumbed.Multilocus sequence typing revealed that the MenB strain that caused the outbreak belonged to an existing sequence type in the United Kingdom, ST-485, part of the clonal complex 41/44 lineage [1,2].